Home › Funds › ACUTA CAPITAL PARTNERS, LLC › UTHR
ACUTA CAPITAL PARTNERS, LLC position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 2,224 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$1.2M, representing 0.84% of its reported portfolio and ranking #21 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's UTHR position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in UTHR in Q3 2025 at 2,296 shares (US$963K). The position peaked in Q1 2026 at 2,224 shares, worth US$1.3M. Across 4 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,224 shares valued at US$1.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 2.30K | $962.51K | New |
| Q4 2025 | 2.30K | $1.12M | Hold |
| Q1 2026 | 2.22K | $1.32M | Reduce |
| Q2 2026 | 2.22K | $1.21M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.71M sh · $925.85M · Q2 2026
- ASSETMARK, INC 624.07K sh · $338.14M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held UTHR?
ACUTA CAPITAL PARTNERS, LLC has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is ACUTA CAPITAL PARTNERS, LLC's current position in UTHR?
As of Q2 2026, ACUTA CAPITAL PARTNERS, LLC holds 2.22K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $1.21M, representing 0.84% of its reported portfolio and ranking #21.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling UTHR?
In the latest 13F filing (Q2 2026), ACUTA CAPITAL PARTNERS, LLC held unchanged its position in UTHR. The position peaked in Q1 2026 at 2.22K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.